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Abstract 28 
Titin provides a molecular blueprint for muscle sarcomere assembly and sarcomere length can vary 29 
according to titin isoform expression.  If variations in sarcomere length influence muscle fascicle 30 
length, this may provide an advantage for running performance. Thus the aim of this study was to 31 
investigate if the titin (TTN) rs10497520 polymorphism was associated with muscle fascicle length in 32 
recreationally active men (RA; n = 137) and marathon personal best time in male marathon runners 33 
(MR; n = 141).  Fascicle length of the vastus lateralis was assessed in vivo using B-mode 34 
ultrasonography at 50% of muscle length in RA.  All participants provided either a whole blood, saliva 35 
or buccal cell sample, from which DNA was isolated and genotyped using real-time polymerase chain 36 
reaction.  Vastus lateralis fascicle length was 10.4% longer in CC homozygotes, those carrying two 37 
copies of the C-allele, than CT heterozygotes (p = 0.003) in RA.  In the absence of any TT 38 
homozygotes, reflective of the low T-allele frequency within Caucasian populations, it is unclear if 39 
fascicle length for this group would have been smaller still.  No differences in genotype frequency 40 
between the RA and MR groups were observed (p = 0.500), although within the MR group the T-allele 41 
carriers demonstrated marathon personal best times 2 min 25 s faster than CC homozygotes (p = 42 
0.020).  These results suggest that the T-allele at rs10497520 in the TTN gene is associated with 43 
shorter skeletal muscle fascicle length and conveys an advantage for marathon running performance in 44 
habitually trained men. 45 
 46 
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Introduction 48 
The titin gene (TTN) encodes the largest described protein to date, which is the third most abundant 49 
protein within the myofilament of human striated muscle (Vikhlyantsev & Podlubnaya 2012).  Titin 50 
provides a molecular blueprint for the assembly and organisation of the thin and thick filaments during 51 
myofibrillogenesis (Chauveau et al. 2014).  Seven splice isoform variants of titin exist within human 52 
striated muscle, which each differ in size and elasticity (Chauveau et al. 2014; Vikhlyantsev & 53 
Podlubnaya 2012).   54 
 55 
A missense C>T transition (rs10497520), where the more common C-allele is replaced by the T-allele, 56 
has been identified within human TTN and reportedly contributes to the variability in the training 57 
response of maximal oxygen consumption (VO2max) in previously untrained individuals (Timmons et 58 
al. 2010).  Within cardiac muscle, titin is suggested to be a key regulator of the Frank-Starling 59 
mechanism (Fukuda et al. 2001), and considering the substantial differences in the elasticity of cardiac 60 
titin isoforms (Wang et al. 1991), this C>T transition may contribute to the variability within titin 61 
isoform expression.  Accordingly, differences in the titin isoforms expressed may explain the TTN-62 
related increases in stroke volume (Rankinen et al. 2003) and consequently VO2max following 63 
endurance exercise training (Timmons et al. 2010).  Furthermore, if this TTN polymorphism influences 64 
titin isoform expression in cardiac muscle as speculated, there exists a distinct possibility that a similar 65 
influence is occurring within skeletal muscle tissue.   66 
 67 
In skeletal muscle, the predominant titin isoform is N2A, of which a smaller (T1) and larger (T2) 68 
isovariant exist within humans (Fry et al. 1997).   A recent study, which identified a TTN mutation that 69 
alters isoform splicing in rats, demonstrated an association between isoform size and sarcomere 70 
length; with significantly longer resting sarcomere lengths corresponding to the larger mutant titin 71 
isoforms (Greaser & Pleitner 2014; Greaser et al. 2008).  Assuming a linear relationship between 72 
fascicle length and in series sarcomere number (Herzog et al. 1990), it follows that fascicles 73 
expressing larger titin isoforms could be longer than those expressing smaller titin isoforms.  It is 74 
important to note, however, that there was no association between titin isoform size and resting 75 
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sarcomere length in wild-type rats, those without the larger mutant titin isoform in the aforementioned 76 
study (Greaser & Pleitner 2014).  Furthermore, evidence exists demonstrating the non-uniform 77 
distribution of sarcomere length within fascicles of the same muscle and different muscles (Greaser et 78 
al. 2005; Wickiewicz et al. 1983), thus understanding the potential influence of titin on skeletal muscle 79 
architecture in humans appears complex.   80 
 81 
If TTN-dependent differences in skeletal muscle fascicle length are apparent, variability in muscle 82 
functional phenotypes might also be expected.  For instance, muscle maximal shortening velocity 83 
(Vmax) is positively correlated with fascicle length (Bodine et al. 1982; Sacks & Roy 1982).  Although 84 
no direct associations between TTN and fascicle length have been reported, the aforementioned C>T 85 
transition within the TTN gene has been identified as contributing significantly to a genetic 86 
predisposition for maximal isokinetic strength at 180°∙s-1 but not 60°∙s-1 (Thomaes et al. 2013), which 87 
could indirectly demonstrate that variability in Vmax is influenced by genotype-dependent differences 88 
in fascicle length.  Furthermore, enhanced efficiency of stretch-shortening contractions can be 89 
expected in individuals possessing shorter muscle fascicles due to the lower metabolic cost of 90 
producing a given force.  More specifically, shorter fascicles produce the same force per unit cross-91 
sectional area as longer fascicles, but when producing a given force, a smaller volume of muscle is 92 
activated in individuals possessing shorter fascicles (Pontzer et al. 2009; Roberts et al. 1998).  93 
Accordingly, vastus lateralis and gastrocnemius muscle fascicle length is shorter in elite distance 94 
runners than elite sprinters and untrained controls, and longer in elite sprinters than untrained controls 95 
(Abe et al. 2000).  Shorter fascicles in elite distance runners are likely to contribute to improved 96 
mechanical efficiency, whereas the longer fascicles observed in elite sprinters is likely to contribute to 97 
enhanced Vmax.  To date, however, it remains unclear whether these differences in the muscle 98 
architecture of elite runners are the result of adaptations to training or genetic variation. 99 
 100 
Consequently, the present study aimed to investigate if the TTN rs10497520 polymorphism was 101 
associated with muscle fascicle length in recreationally active men, and to investigate if TTN genotype 102 
distribution differed between recreationally active men and trained male marathon runners.  It was 103 
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hypothesized that the TTN polymorphism would be associated with muscle fascicle length in 104 
recreationally active men, and the genotype associated with shorter fascicle length in this population 105 
would be overrepresented in trained marathon runners. 106 
 107 
Materials and methods 108 
The sample comprised 278 healthy, unrelated Caucasian men who were categorised as either 109 
recreationally active [RA; n = 137, age 20.6 (2.3) yr, height 1.79 (0.06) m, mass 75.1 (10.1) kg; mean 110 
(standard deviation; SD)] or habitually trained marathon runners [MR; n = 141, age 34.9 (7.8) yr; 111 
height 1.79 (0.07) m, mass 66.5 (6.7) kg].  RA participants were primarily recruited through mail-outs, 112 
posters and word-of-mouth.  RA participants were excluded from participation if they had a body mass 113 
index (BMI) below 18.5 kg∙m-2 or above 30 kg∙m-2, self-reported as having a known musculoskeletal 114 
or neurological disorder and/or had undertaken any structured training in the preceding 12 months.  115 
MR participants comprised Olympic, international and national level marathon runners and were 116 
included if they had achieved marathon personal best times under 2 hr 36 mins (range ~2 hr 7 mins to 117 
~2 hr 35 mins).  MR participants were primarily recruited from London Marathon competitors at the 118 
London Marathon Expos during 2013-2015 and regional athletics clubs and organisations via mail-119 
outs, posters and word-of-mouth.  All participants gave written informed consent to participate in this 120 
study, which received approval from the Ethics Committee of Manchester Metropolitan University 121 
and complied with the Declaration of Helsinki. 122 
 123 
Muscle fascicle length of the vastus lateralis (VL) was measured in vivo using B-mode 124 
ultrasonography (AU5, Esaote, Italy) for each RA participant.  VL muscle length of the right limb was 125 
measured at rest following identification of the VL origin and insertion, whilst participants were 126 
standing upright with knees extended and relaxed (Abe et al. 2000).  Whilst in this position, ultrasound 127 
scans were taken at 50% of VL muscle length, in the mid-sagittal plane, using a 40 mm wide, 7.5 MHz 128 
linear-array probe positioned perpendicular to the skin.  Although the knee joint angle during standing 129 
does not correspond to that of optimal force production during running (Novacheck 1998; Tsuji et al. 130 
2015), measurement of fascicle length in this position is highly reproducible.  Each ultrasound scan 131 
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was recorded using a 25 Hz sampling frequency in audio video interleave (AVI) format and frame-132 
capture software (Adobe Premiere Elements version 10, Adobe Systems) was used to capture single 133 
images for subsequent analysis.  The distance between fascicular origin in the lower aponeurosis and 134 
insertion in the upper aponeurosis was measured as fascicle length using digitizing software (NIH 135 
ImageJ, version 1.44o, National Institute of Health, Bethesda, Maryland).  Measurement of fascicle 136 
length in all instances required extrapolation of the superficial and deep aponeuroses to allow for 137 
estimation of fascicle length, due to fascicles extending beyond the ultrasound field of view (Reeves & 138 
Narici 2003).  For each participant a minimum of three fascicles were measured and a mean of these 139 
was taken as fascicle length.  Due to the field-based nature of data collection within MR, it was not 140 
possible to obtain measurements of fascicle length in this population.   141 
 142 
All participants provided either a blood, saliva or buccal cell sample using the following protocols.  143 
For blood sampling, a 5 mL sample was taken from a superficial forearm vein into EDTA tubes (BD 144 
Vacutainer Systems, Plymouth, UK) and stored at -20°C.  Saliva samples were collected following a 145 
minimum 30-minute abstinence from food and drink into Oragene DNA OG-500 collection tubes 146 
(DNA Genotek Inc., Ontario, Canada) in accordance with the manufacturer’s guidelines and stored at 147 
room temperature.  Buccal cell samples were collected in duplicate (Whatman Sterile, OmniSwab, GE 148 
Healthcare, USA) following a minimum 1-hour abstinence from food and drink.  Participants were 149 
instructed to brush one OmniSwab collection tip firmly against the inside of the cheek for 150 
approximately 30 s and repeat with a second swab on the opposite cheek.  Each collection tip was 151 
ejected into a 2 mL microcentrifuge tube and stored at -20°C.   152 
 153 
The Qiagen QIAcube spin protocol (Qiagen, Crawley, UK), used for the extraction of genomic DNA 154 
from whole blood, saliva and buccal cell samples, was completed in accordance with the 155 
manufacturer’s guidelines and used the buffers contained in the Qiagen DNA Blood Mini Kit.  Each 156 
participant was genotyped for the TTN rs10497520 polymorphism, using real-time PCR on 96-well 157 
plates.  The 10 μL reaction volume, for genotyping using DNA obtained from whole blood or saliva 158 
samples, contained 0.2 μL of participant DNA [9.9 (1.1) ng, amounts determined using ~20% of 159 
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participant DNA samples], 5 μL of TaqMan genotyping master mix (Applied Biosystems, Paisley, 160 
UK), 4.3 μL of nuclease-free H2O (Qiagen) and 0.5 μL of TaqMan SNP genotyping assay (Applied 161 
Biosystems).  For DNA samples obtained from buccal cells, the 10 μL reaction volume contained 1 μL 162 
of participant DNA [18.6 (4.6) ng], 5 μL of TaqMan genotyping master mix, 3.5 μL of nuclease-free 163 
H2O and 0.5 μL of TaqMan SNP genotyping assay.  In the control wells, the DNA sample was 164 
replaced by nuclease-free H2O. 165 
 166 
DNA amplification (StepOnePlus Real-Time PCR System, Applied Biosystems) was completed using 167 
the following protocol: an initial 10 min at 95°C followed by 40 cycles of denaturation for 15 s at 168 
92°C, primer annealing and extension for 1 min at 60°C and plate read.  TTN genotype was 169 
subsequently determined using StepOnePlus analysis software version 2.3 (Applied Biosystems).  170 
Genotypes were called based on reporter dye intensity and visualized using cluster plots. The TaqMan 171 
assays included VIC and FAM dyes that for rs1049752 indicated C and T alleles on the forward DNA 172 
strand, respectively. Thus, VIC/FAM were interpreted as: 5′- TCCAACTT[C/T]AGGTTCTT -3′. All 173 
samples were analysed in duplicate and 100% agreement between all duplicate samples was achieved. 174 
 175 
Genotype frequency of the TTN rs10497520 polymorphism was assessed for compliance with Hardy-176 
Weinberg equilibrium using a X2 test.  Due to the low number of TT homozygotes in the whole sample 177 
(RA, n = 0; MR, n = 1), CC homozygotes were compared to T-allele carriers within each sub-group 178 
(RA, CC vs. CT; MR, CC vs. CT+TT).  Independent samples t-tests were conducted to determine any 179 
significant differences in physical characteristics (height, mass, BMI and age) between RA and MR, 180 
and according to genotype.  Additionally, independent samples t-tests were conducted to identify any 181 
genotype differences in fascicle length in RA and marathon personal best time in MR.  Pearson’s X2 182 
tests were used to compare genotype frequencies between MR and RA.  All statistical analyses were 183 
performed using SPSS version 21 and alpha was set at 0.05.  Data are presented as mean (SD) unless 184 
otherwise stated. 185 
 186 
Results 187 
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Genotype frequency of the TTN rs10497520 polymorphism was in Hardy-Weinberg equilibrium for 188 
the whole sample and both the RA and MR sub-groups (Table 1).  MR were older and had lower mass 189 
(~9 kg) and BMI than RA (all differences p ≤ 1.0 x 10-13), but there was no difference in height (p = 190 
0.660).  Genotype was not associated with mass, BMI or height either within the RA or MR 191 
subgroups, nor in the combined sample of 278 participants (p ≥ 0.376; Table 1). 192 
 193 
In the RA sub-group, VL fascicle length was 10.4% longer in CC homozygotes than in CT 194 
heterozygotes (p = 0.003; Figure 1).  Furthermore, when VL fascicle length was normalised to VL 195 
muscle length, VL fascicle length remained significantly longer in CC homozygotes than in CT 196 
heterozygotes (11.7%, p = 0.035).  There were no differences in genotype frequency between the RA 197 
and MR groups (X2 = 1.385, p = 0.500).  However, marathon personal best time was significantly 198 
lower in T-allele carriers compared to CC homozygotes in the MR group [2:26:28 (0:06:23) vs. 199 
2:28:53 (0:05:50); p = 0.020; Figure 2]. 200 
 201 
Discussion 202 
The aims of the present study were to investigate whether VL muscle fascicle length was associated 203 
with TTN rs10497520 genotype in recreationally active Caucasian men, and to identify whether 204 
differences in genotype frequency were evident between recreationally active individuals and trained 205 
marathon runners.  This study is the first to show a genetic influence on muscle architecture; 206 
specifically, the results demonstrate that VL muscle fascicle length was significantly longer in TTN 207 
CC homozygotes compared to CT heterozygotes in RA.  This is also the first time marathon 208 
performance in trained runners was associated with TTN genotype, with T-allele carriers performing 209 
significantly better than CC homozygotes.  210 
 211 
Titin acts as a template for myofibrillar protein assembly during sarcomere formation and provides an 212 
attachment site for a plethora of myofibrillar proteins to maintain the structural integrity of the 213 
sarcomere (Chauveau et al. 2014).  This protein is therefore likely to play a key role in the architecture 214 
of skeletal muscle, possibly affecting the serial arrangement of sarcomeres and, therefore, the length of 215 
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muscle fascicles (Greaser & Pleitner 2014; Greaser et al. 2008).  Mean VL fascicle length in the RA 216 
group [7.1 (1.5) cm] was comparable to some previous reports of VL fascicle length (~7 cm) (Abe et 217 
al. 2000; Fukunaga et al. 1997), but less than others (~8 cm and ~9 cm) (Erskine et al. 2009; Reeves et 218 
al. 2004).  Differences in participant positioning and muscle activation during the measurement of 219 
muscle fascicle length are likely to explain the reported differences between the present study and 220 
reports elsewhere (Fukunaga et al. 1997).  Indeed, VL fascicle length was measured during standing 221 
with the knees extended and relaxed in the present study, which was similar to those studies reporting 222 
comparable fascicle lengths (Abe et al. 2000; Fukunaga et al. 1997).  Those studies observing longer 223 
muscle fascicle lengths positioned the knee at 60-90 flexion and obtained measurements during 224 
maximal voluntary contraction (Erskine et al. 2009; Reeves et al. 2004). 225 
 226 
The TTN genotype and allele frequencies observed in the present study were similar to previous 227 
reports in Caucasian populations (www.hapmap.org) (Gibbs et al. 2003).  In the present study, 228 
individuals homozygous for the major C-allele had longer VL fascicles than heterozygotes, but as no 229 
individuals homozygous for the minor T-allele were present in the RA group, reflective of the low 230 
frequency of the T-allele within a Caucasian population, it is unclear if the VL fascicles of TT 231 
homozygotes would have been smaller still.  Future research should attempt to replicate the observed 232 
association between TTN and fascicle length on larger cohorts that include a sufficient number of TT 233 
homozygotes.  Based on the T-allele frequency we observed, future studies would require 2000 234 
participants to recruit 20 TT homozygotes.  A “stress the genotype” approach (Montgomery et al. 235 
2002) could help prioritise recruitment of TT homozygotes prior to conducting time-consuming 236 
phenotype assessments.  Furthermore, as fascicle length is known to vary between muscles (Erskine et 237 
al. 2009; Kawakami et al. 1998; Morse et al. 2008), future research should also include measurements 238 
of fascicle length from multiple muscles (i.e. gastrocnemius and soleus) to establish if the observed 239 
association with TTN genotype is consistent across different muscle groups, or specific to the vastus 240 
lateralis. 241 
 242 
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Nonetheless, it is possible that the presence of the T-allele affects TTN splicing thus increasing 243 
expression of a smaller titin isoform within the muscle fascicles of heterozygotes.  To date, seven 244 
different titin splice isoforms have been identified within human striated muscle that each differ in size 245 
(Vikhlyantsev & Podlubnaya 2012).  Within human skeletal muscle, the predominant titin isoform is 246 
N2A, of which two isovariants (T1 and T2) are known to exist (Fry et al. 1997).  Thus, it is possible 247 
that altered TTN splicing, due to the presence of the T-allele, may influence the expression of these 248 
N2A isovariants and might explain the current observations.  Earlier studies in rat cardiac muscle 249 
support these possibilities by demonstrating a link between a TTN mutation and alternative isoform 250 
splicing (Greaser et al. 2005) and, more recently, TTN was associated with both cardiac and skeletal 251 
muscle sarcomere length in rats (Greaser & Pleitner 2014; Greaser et al. 2008).  Individuals with 252 
longer fascicles (CC homozygotes) would in theory experience a rightward shift in their length-tension 253 
relationship and, potentially, larger optimal joint angles for maximal torque production.  Such a shift 254 
in the length-tension relationship has been linked to a reduction in injury occurrence, as a longer 255 
optimum muscle length would ensure that less of the muscle’s functional range would be along the 256 
more unstable descending limb of the length-tension curve (Brughelli & Cronin 2007).  Thus, in 257 
populations at increased risk of injury, such as athletes, it may be necessary to tailor training 258 
interventions specific to TTN genotype. 259 
 260 
Considering the observed association between TTN genotype and VL fascicle length, it was 261 
hypothesized that T-allele carriers would be overrepresented in habitually trained marathon runners 262 
because shorter fascicles require less energy to produce a given force, which is likely to contribute to 263 
improved mechanical efficiency in this population (Pontzer et al. 2009).  No difference, however, in 264 
TTN genotype distribution was observed between the RA and MR groups.  Nonetheless, the MR T-265 
allele carriers (those expected to possess shorter fascicles according to our RA data) had marathon 266 
personal best times 2 min 25 s faster than MR CC homozygotes.  This observation is consistent with 267 
previous reports of elite distance runners possessing shorter fascicles than both untrained individuals 268 
and elite sprinters (Abe et al. 2000).  Thus, possession of the T-allele, whilst not essential for 269 
successful marathon running performance, might convey an advantage for marathon running when 270 
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combined with appropriate training and nutritional regimens as could be expected of the habitually 271 
trained runners included in the present study.   272 
 273 
Despite observing associations between TTN genotype and VL fascicle length in RA and marathon 274 
personal best time in MR, it remains unclear whether marathon personal best time was enhanced in the 275 
MR T-allele carriers as a consequence of possessing a shorter fascicle length, as this was not directly 276 
measured in the MR group.  As titin is suggested to be a key regulator of the Frank-Starling 277 
mechanism, the influence of TTN within cardiac muscle could provide an alternative explanation for 278 
the observed association between TTN genotype and MR personal best time.  TTN-related increases in 279 
stroke volume following endurance training have been observed previously (Rankinen et al. 2003) and 280 
the rs10497520 polymorphism appears to contribute to the training response of VO2max in previously 281 
untrained individuals (Timmons et al. 2010).  Interestingly, however, Timmons et al. (2010) observed 282 
greater gains in VO2max in CC homozygotes (those expected to have longer VL fascicles) than T-allele 283 
carriers (those expected to have shorter VL fascicles), with gains experienced by heterozygotes similar 284 
to those of TT homozygotes following training.  For untrained participants, such as those in Timmons 285 
et al., training-induced increases in VO2max are primarily due to increases in cardiac output via 286 
increases in stroke volume (Ekblom et al. 1968; Iwasaki et al. 2003) and might be accentuated in 287 
individuals possessing the CC genotype.  However, in highly trained athletes with comparable rates of 288 
maximal oxygen uptake, as could be expected of the trained MR group, other factors such as lactate 289 
threshold and running economy are probably more important in determining performance (Conley & 290 
Krahenbuhl 1980).  Moreover, improved running economy in individuals possessing lower ratios of 291 
titin isoforms (T1/T2) has recently been reported (Pellegrino et al. 2016), although more research is 292 
required to investigate whether the rs10497520 T-allele corresponds to lower T1/T2 ratios.  Thus, 293 
despite a potential pleiotropic influence of TTN on both cardiac and skeletal muscle, possession of the 294 
T-allele (and consequently shorter VL fascicles) appears more important for marathon performance in 295 
trained individuals. 296 
 297 
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Finally, as RA CC homozygotes possessed longer VL fascicles, an association of this genotype with 298 
successful sprint running performance is possible.  Longer muscle fascicles are known to contribute to 299 
enhanced Vmax (Bodine et al. 1982; Sacks & Roy 1982), which is an important determinant of sprint 300 
performance (Kumagai et al. 2000).  Thus, trained sprinters with the CC genotype might possess 301 
longer muscle fascicles and enhanced sprint ability compared to trained sprinters carrying the T-allele.  302 
Future research should investigate the impact of TTN genotype on sprint performance in addition to 303 
running economy, mechanical efficiency and Vmax, to enhance our understanding of these associations. 304 
  305 
Conclusion and Perspective 306 
Here we report, for the first time, a genetic influence on human skeletal muscle architecture.  The T-307 
allele at the rs10497520 polymorphism in TTN, the gene encoding the giant structural protein titin, is 308 
associated with shorter VL muscle fascicles in recreationally active men, and faster marathon 309 
performance (nearly 2.5 minutes faster) in habitually trained male runners with personal best times of 310 
approximately 2.5 hours.  Considering shorter muscle fascicles require less energy to produce a given 311 
force, the genotype-dependent differences in marathon personal best times may be due to differences 312 
in mechanical efficiency between T-allele carriers and CC homozygotes.   313 
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Table 1. TTN rs10497520 genotype frequency and physical characteristics for RA and MR 
participants.  Frequency data presented as count (%), all other data presented as mean (SD). 
  All CC  CT TT p X2 
 Frequency (%) 137 (100) 110 (80.3) 27 (19.7) 0 (0.0) 0.441 1.637 
R
A
 
Height (m) 1.79 (0.06) 1.79 (0.06) 1.80 (0.07) - 0.437  
Mass (kg) 75.3 (10.1)* 75.0 (9.9) 76.3 (11.1) - 0.376  
BMI (kg∙m-2) 23.5 (2.7)* 23.5 (2.7) 23.6 (3.0) - 0.806  
Age (yr) 20.7 (2.7)* 20.8 (2.6) 20.6 (3.1) - 0.768  
 VL fascicle length (cm) 7.1 (1.5) 7.3 (1.6) 6.4 (0.9) - 0.003  
 VL fascicle length/VL 
muscle length  
0.17 (0.05) 0.18 (0.05) 0.16 (0.03) - 0.035  
        
 Frequency (%) 141 (100) 108 (76.6) 32 (22.7) 1 (0.7) 0.756 0.561 
M
R
 
Height (m) 1.79 (0.07) 1.78 (0.07) 1.79 (0.06) 1.82 0.675  
Mass (kg) 66.6 (6.7) 66.7 (6.8) 66.0 (6.6) 66.0 0.551  
BMI (kg∙m-2) 20.9 (1.9) 21.0 (2.0) 20.6 (1.6) 19.9 0.285  
 Age (yr) 34.9 (7.8) 34.3 (6.7) 37.0 (10.6) 31.0 0.196  
 Marathon PB Time 
(hr:min:s) 
2:28:31 
(0:06:17) 
2:28:53 
(0:05:50) 
2:26:25 
(0:06:12) 
2:27:08 0.020  
        
T
O
T
A
L
 
Frequency (%) 278 (100) 218 (78.4) 59 (21.2) 1 (0.4) 0.385 1.908 
Height (m) 1.79 (0.07) 1.79 (0.07) 1.79 (0.06) 1.82 0.415  
Mass (kg) 70.8 (9.6) 70.9 (9.4) 70.7 (10.4) 66.0 0.834  
BMI (kg∙m-2) 22.2 (2.7) 22.2 (2.7) 21.9 (2.7) 19.9 0.452  
 Age (yr) 27.9 (9.2) 27.5 (8.5) 29.5 (11.5) 31.0  0.196  
RA, untrained; MR, habitually trained marathoners; BMI, body mass index; PB, personal best; p 
relates to two-group analyses (CC vs. CT in RA and CC vs. CT+TT in MR) except for frequency 
analyses when this includes all genotype groups; * denotes significant difference between RA and 
MR (p ≤ 1.0 x 10-13). 
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Figure 1. Comparison of VL fascicle length by TTN CC (n = 110) and CT (n = 27) genotype in RA (*p 397 
= 0.003).  No TT homozygotes were identified. Columns and error bars are mean and SD. 398 
 399 
Figure 2. Comparison of marathon personal best time between TTN CC genotype (n = 108) and T-allele 400 
carriers (n = 33) in MR (*p = 0.020). Columns and error bars are mean and SD. 401 
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